Novartis AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Current	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Apr '26 Apr 16, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021	Jun '21 Jun 30, 2021
Market Cap	285,759	263,077	246,066	234,258	218,418	192,196	229,959	215,537	197,369	206,386	198,126	197,498	182,599	181,968	154,720	174,601	183,733	184,986	173,129	193,120
Market Cap Growth	30.83%	36.88%	7.00%	8.69%	10.66%	-6.88%	16.07%	9.13%	8.09%	13.42%	28.06%	13.11%	-0.62%	-1.63%	-10.63%	-9.59%	1.17%	-8.27%	-7.50%	2.08%
Enterprise Value	310,378	281,498	260,973	251,391	234,532	201,753	241,409	228,494	206,476	212,075	205,033	206,212	192,407	184,901	156,930	178,708	189,456	181,347	189,848	214,341
Last Close Price	149.73	137.87	128.24	121.01	111.48	97.31	115.02	106.46	96.73	100.97	96.39	95.49	87.06	85.85	71.93	79.99	83.04	82.77	77.39	86.34
PE Ratio	20.43	19.28	17.54	17.64	17.45	16.55	13.41	13.54	13.11	14.12	25.91	26.60	26.79	27.17	7.40	7.83	7.74	7.77	17.87	21.86
PS Ratio	5.04	4.64	4.37	4.24	4.10	3.72	4.60	4.41	4.13	4.42	4.32	4.43	3.98	3.82	3.08	3.31	3.47	3.50	3.30	3.75
PB Ratio	6.14	5.70	5.55	5.58	5.69	4.36	5.31	5.16	4.97	4.42	5.19	3.81	3.51	3.07	2.54	2.77	2.99	2.73	3.05	3.57
P/TBV Ratio	6.34	5.77	5.61	5.65	5.75	4.43	5.38	5.22	5.01	4.47	5.24	3.86	3.55	3.11	2.58	2.81	3.02	2.76	3.07	3.61
P/FCF Ratio	16.24	14.95	12.57	12.12	12.41	11.83	15.58	15.49	15.61	15.48	13.21	13.74	12.57	13.79	12.07	13.55	13.92	13.51	12.59	16.02
P/OCF Ratio	14.93	13.74	11.68	11.27	11.50	10.91	14.40	14.31	14.34	14.27	12.37	12.85	11.75	12.78	11.04	12.28	12.59	12.27	11.40	14.39
EV/Sales Ratio	5.48	4.97	4.63	4.56	4.41	3.90	4.83	4.68	4.33	4.55	4.47	4.63	4.19	3.88	3.13	3.39	3.57	3.43	3.62	4.16
EV/EBITDA Ratio	13.22	12.28	11.37	11.66	11.38	9.77	12.27	15.76	14.87	11.68	16.12	13.94	15.42	11.83	9.71	11.64	11.41	10.51	10.63	15.21
EV/EBIT Ratio	16.33	15.95	14.86	15.07	14.81	13.87	17.76	19.48	19.62	21.71	22.93	22.90	22.83	21.35	16.57	16.43	15.62	15.51	16.13	19.57
EV/FCF Ratio	17.64	16.00	13.33	13.01	13.32	12.41	16.36	16.43	16.33	15.91	13.68	14.34	13.25	14.01	12.25	13.87	14.35	13.24	13.80	17.78
Debt / Equity Ratio	0.64	0.64	0.54	0.57	0.60	0.52	0.58	0.51	0.47	0.43	0.51	0.38	0.42	0.37	0.35	0.38	0.39	0.36	0.43	0.49
Debt / EBITDA Ratio	1.55	6.88	5.53	5.34	6.71	6.05	5.74	5.62	8.09	6.29	14.30	6.24	6.27	15.93	7.45	13.95	7.19	7.60	7.34	10.30
Debt / FCF Ratio	2.02	21.42	5.15	5.15	9.22	8.64	5.39	6.28	13.39	12.35	4.92	8.46	10.74	7.35	6.34	8.89	22.52	9.08	7.51	9.41
Net Debt / Equity Ratio	0.52	0.52	0.50	0.61	0.63	0.41	0.42	0.49	0.44	0.26	0.33	0.33	0.33	0.15	0.16	0.18	0.20	0.04	0.46	0.56
Net Debt / EBITDA Ratio	1.04	4.63	3.84	4.19	5.16	3.46	3.24	3.99	5.22	2.86	7.09	3.78	3.64	5.15	2.46	5.09	2.87	0.68	5.59	8.76
Net Debt / FCF Ratio	1.36	14.42	3.58	4.05	7.10	4.94	3.04	4.45	8.63	5.61	2.44	5.12	6.23	2.37	2.10	3.24	9.00	0.81	5.72	8.00
Asset Turnover	0.13	0.13	0.14	0.15	0.14	0.13	0.12	0.12	0.12	0.11	0.10	0.10	0.09	0.09	0.09	0.11	0.10	0.10	0.11	0.11
Inventory Turnover	2.28	0.60	0.57	0.55	0.56	0.57	0.56	0.45	0.45	0.46	0.50	0.44	0.40	0.44	0.42	0.54	0.55	0.58	0.56	0.56
Quick Ratio	0.76	0.76	0.59	0.51	0.50	0.73	0.79	0.61	0.61	0.83	0.41	0.65	0.70	0.95	0.99	1.04	0.92	1.21	0.56	0.47
Current Ratio	1.12	1.12	0.88	0.82	0.79	1.04	1.11	0.93	0.90	1.16	0.94	1.00	1.05	1.29	1.31	1.38	1.25	1.51	0.88	0.80
Return on Equity (ROE)	5.30%	5.30%	8.91%	9.59%	9.23%	6.21%	7.80%	6.92%	5.85%	4.97%	3.05%	3.95%	3.78%	2.07%	2.26%	2.89%	3.95%	26.20%	4.95%	5.36%
Return on Assets (ROA)	2.53%	2.53%	4.00%	4.28%	3.93%	3.00%	3.16%	3.25%	2.81%	2.64%	1.49%	2.04%	1.88%	1.18%	1.28%	1.50%	1.92%	1.90%	2.20%	2.32%
Return on Invested Capital (ROIC)	3.60%	3.60%	5.74%	5.83%	5.56%	4.40%	4.48%	4.52%	3.99%	3.93%	2.10%	2.90%	2.69%	1.83%	1.73%	1.99%	2.55%	2.77%	2.83%	2.86%
Return on Capital Employed (ROCE)	4.60%	4.60%	5.97%	6.82%	6.99%	4.80%	5.19%	5.39%	4.60%	3.18%	2.28%	3.22%	2.96%	1.84%	2.01%	2.35%	3.05%	2.61%	3.42%	3.69%
Earnings Yield	4.89%	5.19%	5.70%	5.67%	5.73%	6.04%	7.46%	7.38%	7.63%	7.08%	3.86%	3.76%	3.73%	3.68%	13.51%	12.78%	12.92%	12.87%	5.60%	4.57%
FCF Yield	6.16%	6.69%	7.96%	8.25%	8.06%	8.46%	6.42%	6.45%	6.41%	6.46%	7.57%	7.28%	7.95%	7.25%	8.28%	7.38%	7.18%	7.40%	7.94%	6.24%
Dividend Yield	2.06%	0.00%	0.00%	1.05%	2.43%	0.00%	0.00%	1.12%	2.63%	0.00%	0.00%	0.00%	3.95%	0.00%	0.00%	0.00%	4.06%	0.00%	0.00%	0.00%
Payout Ratio	43.09%	0.00%	0.00%	61.49%	147.89%	0.00%	0.00%	74.46%	193.71%	0.00%	0.00%	0.00%	316.40%	0.00%	0.00%	0.00%	337.80%	0.00%	0.00%	0.00%
Buyback Yield / Dilution	3.93%	3.74%	4.29%	4.20%	3.75%	2.95%	2.31%	2.34%	3.02%	3.95%	4.82%	5.25%	5.23%	4.57%	3.28%	2.08%	1.24%	1.27%	2.09%	2.00%
Total Shareholder Return	5.99%	3.74%	4.29%	5.26%	6.18%	2.95%	2.31%	3.46%	5.65%	3.95%	4.82%	5.25%	9.18%	4.57%	3.28%	2.08%	5.30%	1.27%	2.09%	2.00%

Updated Feb 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q